^{PDFprof.com Search Engine}

Novartis Financial Results Q3 2022 French

Is Novartis Q3 2023 a non-IFRS measure?
Novartis Q3 2023 Impact and Sustainability Update (PDF 1.0 MB) Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 48 of the Condensed Interim Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.
How much free cash flow did Novartis generate in 2022?
Free cash flow was USD 4.2 billion (-6% USD) 2022 Group guidance confirmed at mid single digit sales and core operating income growth. Basel, October 25, 2022 - commenting on the quarter, Vas Narasimhan MD, CEO of Novartis, said: “Novartis delivered a solid third quarter, with strong YTD operational performance.
Does Novartis update the information in these pages?
Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates. Novartis announces the company’s fourth quarter and 2022 full year financial results.
Does Novartis have a competitive pipeline?
Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines. Browse and download multimedia resources including images, videos, infographics and more. Novartis announced the company’s financial results for the third quarter of 2022.

Is Novartis Q3 2023 a non-IFRS measure?